Rapid diagnosis of tuberculosis and multidrug resistance by the microscopic-observation drug-susceptibility assay
- PMID: 21297071
- DOI: 10.1164/rccm.201009-1449OC
Rapid diagnosis of tuberculosis and multidrug resistance by the microscopic-observation drug-susceptibility assay
Abstract
Rationale: Mortality is exceedingly high and rapid among patients infected with HIV and tuberculosis (TB), in part because of limited access to appropriate TB diagnostics. The microscopic observation drug-susceptibility (MODS) assay is a simple, rapid, low-cost test for TB and multidrug-resistant (MDR) TB, but data in individuals infected with HIV and in Africa are limited.
Objectives: To evaluate the MODS assay in a high-HIV-prevalence setting.
Methods: We performed a prospective diagnostic accuracy study of consecutive adults suspected to have TB from outpatient and inpatient settings at a district hospital in rural South Africa. Sputum was tested by concentrated smear microscopy; agar (Middlebrook 7H11) and liquid (mycobacterial growth indicator tube) culture; and the MODS assay. Drug-susceptibility testing (DST) was by indirect 1% proportion method and MODS. Reference standard for Mycobacterium tuberculosis detection was growth on Middlebrook or mycobacterial growth indicator tube culture; 1% proportion was the reference standard for isoniazid and rifampin DST.
Measurements and main results: Among 534 adults enrolled, 388 (73%) were HIV-positive, with a median CD4 count of 161 cells/mm(3) (interquartile range [IQR]: 72-307). TB was diagnosed by the reference standard culture in 113 (21%). MODS sensitivity was 85% (95% confidence interval [CI], 78-92%), and specificity was 97% (CI, 95-99%). MODS test performance did not differ by patients' HIV status (sensitivity 88% vs. 90%, specificity 97% vs. 100% for HIV-positive versus HIV-negative, respectively). For MDR-TB diagnosis (n = 11), sensitivity was 100% (one-sided CI, 68-100%) and specificity was 94% (CI, 82-98%). Median turnaround time for MDR-TB diagnosis was 7 days (IQR: 6-9) with MODS versus 70 days (IQR: 49-96) with indirect proportion method (P < 0.001).
Conclusions: Among adult TB suspects predominantly infected with HIV, MODS provided high sensitivity and specificity for rapid diagnosis of TB and MDR-TB. Given the high mortality from TB and MDR-TB and prolonged opportunity for TB transmission before diagnosis, the MODS assay warrants serious consideration for use in similar high-HIV-prevalence, resource-limited settings.
Similar articles
-
Non-commercial phenotypic assays for the detection of Mycobacterium tuberculosis drug resistance: a systematic review.Eur J Clin Microbiol Infect Dis. 2020 Mar;39(3):415-426. doi: 10.1007/s10096-019-03723-8. Epub 2019 Oct 30. Eur J Clin Microbiol Infect Dis. 2020. PMID: 31667670
-
Evaluation of the microscopic observation drug susceptibility assay for the rapid detection of MDR-TB and XDR-TB in China: a prospective multicentre study.J Antimicrob Chemother. 2015 Feb;70(2):456-62. doi: 10.1093/jac/dku384. Epub 2014 Sep 28. J Antimicrob Chemother. 2015. PMID: 25266071
-
A rapid and low-cost microscopic observation drug susceptibility assay for detecting TB and MDR-TB among individuals infected by HIV in South India.Indian J Med Microbiol. 2013 Apr-Jun;31(2):130-7. doi: 10.4103/0255-0857.115225. Indian J Med Microbiol. 2013. PMID: 23867668
-
Evaluation of the microscopic observational drug susceptibility assay for rapid and efficient diagnosis of multi-drug resistant tuberculosis.Indian J Med Microbiol. 2012 Jan-Mar;30(1):64-8. doi: 10.4103/0255-0857.93039. Indian J Med Microbiol. 2012. PMID: 22361763
-
The management of tuberculosis: epidemiology, resistance and monitoring.Dan Med Bull. 2010 Nov;57(11):B4213. Dan Med Bull. 2010. PMID: 21055374 Review.
Cited by
-
Microscopic-observation drug-susceptibility assay for the diagnosis of drug-resistant tuberculosis in Harare, Zimbabwe.PLoS One. 2013;8(2):e55872. doi: 10.1371/journal.pone.0055872. Epub 2013 Feb 11. PLoS One. 2013. PMID: 23409072 Free PMC article.
-
A field evaluation of the Hardy TB MODS Kit™ for the rapid phenotypic diagnosis of tuberculosis and multi-drug resistant tuberculosis.PLoS One. 2014 Sep 16;9(9):e107258. doi: 10.1371/journal.pone.0107258. eCollection 2014. PLoS One. 2014. PMID: 25225802 Free PMC article.
-
Integrating pathogen- and host-derived blood biomarkers for enhanced tuberculosis diagnosis: a comprehensive review.Front Immunol. 2024 Aug 9;15:1438989. doi: 10.3389/fimmu.2024.1438989. eCollection 2024. Front Immunol. 2024. PMID: 39185416 Free PMC article. Review.
-
Molecular Epidemiology and Polymorphism Analysis in Drug-Resistant Genes in M. tuberculosis Clinical Isolates from Western and Northern India.Infect Drug Resist. 2022 Apr 8;15:1717-1732. doi: 10.2147/IDR.S345855. eCollection 2022. Infect Drug Resist. 2022. PMID: 35422638 Free PMC article.
-
Non-commercial phenotypic assays for the detection of Mycobacterium tuberculosis drug resistance: a systematic review.Eur J Clin Microbiol Infect Dis. 2020 Mar;39(3):415-426. doi: 10.1007/s10096-019-03723-8. Epub 2019 Oct 30. Eur J Clin Microbiol Infect Dis. 2020. PMID: 31667670
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials